Same patient, new stone composition: Amprenavir urinary stone

17Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We report here the first case to add amprenavir to the growing list of antiretroviral drugs associated with urinary stones. The first reported case of a nelfinavir urinary stone was reported in 2002 in a 37-year-old HIV-infected woman. In September 2007, the same female patient was referred to our department with recent onset of right flank pain and recurrent urinary tract infections. Abdominal computed tomography revealed three obstructing stones in the distal right ureter, another stone in the right renal pelvis with hydronephrosis and a stone in the left kidney. After stone retrieval, analysis of the stone by liquid chromatography with mass spectrometry revealed a stone composition of 95% unmodified amprenavir and 5% ritonavir. © 2008 International Medical Press.

Cite

CITATION STYLE

APA

Feicke, A., Rentsch, K. M., Oertle, D., & Strebel, R. T. (2008). Same patient, new stone composition: Amprenavir urinary stone. Antiviral Therapy, 13(5), 733–734. https://doi.org/10.1177/135965350801300514

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free